NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle invasive bladder cancer (NMIBC, U.S. prevalence of ~600,000 ...

Despite 80%+ of developers recognizing GenAI’s benefits, adoption lingers below 40%, revealing the GenAI adoption conundrum. Without mastering GenAI today, India cannot transition to Agentic AI ...

India's retail market is poised for significant expansion, projected to reach a staggering INR 190 trillion by 2034, according to a new report, "Winning in Bharat & India: The Retail Kaleidoscope ...